SCHEMBL21647367

SCHEMBL21647367

O=C(O)CCCNC(Cl)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 2/20 0.47
CDC25B P30305 2/20 0.47
ATM Q13315 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
HDAC3 O15379 2/20 0.43
HDAC4 P56524 2/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
HDAC9 Q9UKV0 2/20 0.43
HDAC5 Q9UQL6 2/20 0.43
MAPK1 P28482 1/20 0.43
ADRA1A P35348 1/20 0.43
SLC6A3 Q01959 1/20 0.43
HTT P42858 1/20 0.43
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2953725 0.85 HDAC3 (0.47) CDC25ACDC25BSMN1; SMN2HDAC3HDAC4
SCHEMBL6050938 0.82 ATM (0.49) CDC25ACDC25BATMSMN1; SMN2HDAC3
SCHEMBL11328925 0.82 MTOR (0.61) CDC25ACDC25BATMSMN1; SMN2HDAC3
SCHEMBL15131122 0.79 CYP3A4 (0.56) ATMSMN1; SMN2ADRA1ASLC6A3HTT
SCHEMBL364540 0.79 CYP3A4 (0.56) ATMSMN1; SMN2ADRA1ASLC6A3HTT
SCHEMBL21490939 0.78 EPHX2 (0.48) CDC25ACDC25BATMSMN1; SMN2HDAC3
SCHEMBL21490940 0.78 EPHX2 (0.48) CDC25ACDC25BATMSMN1; SMN2HDAC3
SCHEMBL6050947 0.77 TBXA2R (0.49) CDC25ACDC25BATMSMN1; SMN2HDAC3
SCHEMBL6050941 0.77 TBXA2R (0.49) CDC25ACDC25BATMSMN1; SMN2HDAC3
SCHEMBL27579422 0.77 MTOR (0.59) CDC25ACDC25BSMN1; SMN2HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260071008-A1 HYDROPHOBICALLY MODIFIED CELLULOSE FIBERS AND METHOD FOR PRODUCING SAME KUREHA CORPORATION (JP) 2026-03-12 US disclosed
EP-4582460-A1 HYDROPHOBICALLY MODIFIED CELLULOSE FIBERS AND METHOD FOR PRODUCING SAME Kureha Corporation (JP) 2025-07-09 EP disclosed
WO-2024048610-A1 HYDROPHOBICALLY MODIFIED CELLULOSE FIBERS AND METHOD FOR PRODUCING SAME 株式会社クレハ 2024-03-07 WO disclosed
CN-108026275-B Method for producing polyarylene sulfide 株式会社吴羽 2020-05-15 CN disclosed
WO-2020026590-A1 METHOD FOR PRODUCING POLY(ARYLENE SULFIDE) 株式会社クレハ 2020-02-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071008-A1 HYDROPHOBICALLY MODIFIED CELLULOSE FIBERS AND METHOD FOR PRODUCING SAME GANAB, ALG1, GANC CDC25A 4133/4885CDC25B 4675/4885ATM 1194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.